Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 300
Selected: 0
NCT IDTitle
NCT02423603PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
NCT01737255Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
NCT00664781Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
NCT05786716DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
NCT00058032CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
NCT03328247Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma
NCT00755885Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
NCT02960620Therasphere for Unresectable Primary or Secondary Liver Neoplasia
NCT01810757Study of Weekly Radiotherapy for Bladder Cancer
NCT03245177Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT05368298SCOOT: Sample Collection for DART
NCT01460888Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
NCT00908180Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT01737242UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies
NCT00080912Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases
NCT00829205Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
NCT02457156Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy
NCT03307148Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
NCT02042768Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This
NCT03103152A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression
NCT03916510Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer
NCT01118611Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors
NCT01222221Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT01888601TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
NCT00748527Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT02024009Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
NCT05097625Head and Neck Early Relapse Detection Study (HERD)
NCT04868227Scottish Vitamin D Intervention Study
NCT01196715Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
NCT02544308Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
NCT00727584Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression
NCT01431664AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia
NCT01324115NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
NCT06380816A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
NCT03415854Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
NCT05722886DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT05554523How Does Skin Tone Affect Quantitative Photoacoustic Imaging
NCT04842799Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT05830292Use of DRS Probe and Tracking for In-vivo Application
NCT00907036Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma
NCT03466034The Role of Hypoxia as a Selective Pressure for TP53 Mutations
NCT00004209Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT01279967A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma
NCT00863733Study of DMXAA (Now Known as ASA404) in Solid Tumors
NCT066322365G-EMERALD: Amivantamab in Malignant Brain Tumours
NCT00032175Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
NCT00112931Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT05574738A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
NCT07209774Healthspan Connect Programme of Research
NCT05537844Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma